Autoimmune encephalitis associated with NMDA receptor antibodies: specific aspects of providing medical care to the patients in the intensive care and neurology departments of a multidisciplinary hospital. Report 1
https://doi.org/10.51922/2074-5044.2026.4.140
Abstract
Autoimmune encephalitis (AE) is a severe but potentially curable disease of the central nervous system. One of the main representatives of AE is anti-NMDA receptor AE (autoimmune encephalitis with antibodies to NMDAtype glutamate receptors). The disease is characterized by polymorphic symptoms (neuropsychiatric disorders, dyskinesia, autonomic dysfunction), rapid progression with the development of life-threatening conditions requiring treatment in the intensive care unit (ICU) and a multidisciplinary approach in a multidisciplinary hospital.
This article presents the results of our own clinical observations of the diagnosis and treatment of patients with anti-NMDA receptor AE who were urgently hospitalized in the intensive care unit and the neurology department of a multidisciplinary medical institution (State Institution «432 Order of the Red Star main military Clinical Medical Center of the Armed Forces of the Republic of Belarus») with a discussion of diagnostic features, intensive care, and the most significant aspects of pathogenetic and symptomatic treatment.
About the Authors
A. V. TsitkovaBelarus
K. A. Abdin
Belarus
I. A. Dudko
Belarus
V. V. Malyhin
Belarus
D. M. Bitkouski
Belarus
D. S. Tratsiak
Belarus
A. N. Medvetskaya
Belarus
P. V. Zaretski
Belarus
References
1. Vasenina, E. E., Levin, O. S., Gan’kina, O. A., Poluek- tov, M. G., Gnezdickiy, V. V. Autoimmunniy encefalit s antitelami k NMDA receptoram // Gurnal nevrologii I psihiatrii im. S. S. Korsakova – 2017. – Т. 117, № 2. – S. 110–116. DOI: 10.17116/jnevro201711721110–116.
2. Podzolkova, N. M., Korennaya, V. V, Levin, O. S., Shul’gina, E. V., Kupriyanova, A. V. Autoimmunniy encefalit s antitelami k receptoram N-metil-D-aspartata I teratomy uaichnikov: suschestvuet li vzaimosvyaz’? // Voprosy ginekologii, akusherstva I perinatologii. – 2020. – Т. 19, № 5. – S. 124–131. DOI: 10.20953/1726–1678–2020–5-124–131.
3. Solovej, N. V., Andreeva, E. A. Tyazhelyj autoimmunniy encefalit s antitelami k NMDA receptoram: diagnosticheskie slozhnosti, podhody k terapii (razbor klinicheskogo sluchaya) // Non Nocere. – 2019. – № 4. – URL: http://newtj.awmg.ru/(data obrasheniya: 23.12.2025).
4. Abbatemarco, J. R., Yan, C., Kunchok, A., Rae-Grant, A. Antibody-mediated autoimmune encephalitis: A practical approach // Cleveland Clinic Journal of Medicine. – 2021. – Vol. 88, No. 8. – P. 459–471. DOI: 10.3949/ccjm.88a.20122.
5. Dalmau, J., Tüzün, E., Wu H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., Mason, W., Sansing, L. H., Dichter, M. A., Rosenfeld, M. R., Lynch, D. R. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma // Annals of Neurology. – 2007. – Vol. 61, No. 1. – P. 25–36. DOI: 10.1002/ana.21050.
6. Granerod, J., Ambrose, H. E., Davies, N. W. S., Clew- ley, J. P., Walsh, A. L., Morgan, D., Cunningham, R., Zucker- man, M., Mutton, K. J., Solomon, T., Ward, K. N., Lunn, M. P., Irani, S. R., Vincent, A., Brown, D. W. G., Crowcroft, N. S. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-ba- sed prospective study // The Lancet Infectious Diseases. – 2010. – Vol. 10, No. 12. – P. 835–844. DOI: 10.1016/S1473–3099(10)70222-X.
7. Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Dale, R. C., Gelfand, J. M., Geschwind, M., Gla- ser, C. A., Honnorat, J., Höftberger, R., Iizuka, T., Irani, S. R., Lancaster, E., Leypoldt, F., Prüss, H., Rae-Grant, A., Reindl, M., Rosenfeld, M. R., Rostásy, K., Saiz, A., Venkatesan, A., Vincent, A., Wandinger, K. P., Waters, P., Dalmau, J. A clinical approach to diagnosis of autoimmune encephalitis // Lancet Neurology. – 2016. – Vol. 15, No. 4. – P. 391–404. DOI: 10.1016/S1474–4422(15)00401–9.
8. Lancaster, E. The Diagnosis and Treatment of Autoimmune Encephalitis // Journal of Clinical Neurology. – 2016. – Vol. 12, No. 1. – P. 1–13. DOI: 10.3988/jcn.2016.12.1.1.
9. Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi I., Martinez-Hernandez, E., Aguilar, E., Gresa-Arribas, N., Ryan-Florance, N., Torrents, A., Saiz, A., Rosenfeld, M. R., Balice-Gordon, R., Graus, F., Dalmau, J. Treatment and prognostic factors for long-term outcome in patients with antiNMDA receptor encephalitis: an observational cohort study // Lancet Neurology. – 2013. – Vol. 12, No. 2. – P. 157–165. DOI: 10.1016/S1474–4422(12)70310–1.
10. Zuliani, L., Graus, F., Giometto, B., Bien, C., Vincent, A. Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations // Neurological Sciences. – 2019. – Vol. 40, No. 10. – P. 2017–2030. DOI: 10.1007/s10072–019–03930–3.
Review
For citations:
Tsitkova A.V., Abdin K.A., Dudko I.A., Malyhin V.V., Bitkouski D.M., Tratsiak D.S., Medvetskaya A.N., Zaretski P.V. Autoimmune encephalitis associated with NMDA receptor antibodies: specific aspects of providing medical care to the patients in the intensive care and neurology departments of a multidisciplinary hospital. Report 1. Military Medicine. 2026;(4):140-143. (In Russ.) https://doi.org/10.51922/2074-5044.2026.4.140
JATS XML